MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jacasi.2026.03.019

Медицинская библиотека · JACC. Asia · 2026

Natto Red Yeast Rice Supplement Regulates Lipid Profiles: A Multicenter, Double-Placebo, Double-Blinded, Randomized Controlled Trial.

Liu Fangchao, Chen Shufeng, Liang Fengchao, Li Jianxin, Huang Keyong, Sun Yingxian, Wang Qing, Wu Shouling, Ma Mingfeng, Yu Ling, Lin Jinchun, Lu Xiangfeng, Huang Jianfeng, Gu Dongfeng

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Natto Red Yeast Rice (NRYR) is a dietary supplement used to lower blood lipid. However, evidence on its effects on regulating lipid levels is limited.

OBJECTIVES

The aim of this study was to assess whether NRYR can lower low-density lipoprotein cholesterol (LDL-C) levels and regulate other lipids, both alone and in addition to simvastatin.

METHODS

We enrolled 1,110 participants who were randomized into 4 groups to receive a 3-month intervention of placebo, NRYR (1,950 mg/d), simvastatin (20 mg/d), or NRYR (1,950 mg/d) plus simvastatin (20 mg/d). The primary outcome was the change in LDL-C levels after 3 months, which were evaluated using linear mixed models. The primary analyses were conducted according to the modified intention-to-treat principle. Safety outcomes were also recorded.

RESULTS

Significant reductions in LDL-C levels were observed in the NRYR, simvastatin, and combination group. The differences in the absolute/percent change in LDL-C levels from baseline to 3 months were -21.02 mg/dL (95% CI: -27.98 to -14.06 mg/dL)/-13.21% (95% CI: -17.88% to -8.54%), -25.80 mg/dL (95% CI: -32.64 to -18.97 mg/dL)/-17.08% (95% CI: -21.67% to -12.50%), and -32.74 mg/dL (95% CI: -39.74 to -25.73 mg/dL)/-21.22% (95% CI: -25.92% to -16.52%), respectively, compared with placebo (all P < 0.001). Compared with simvastatin alone, adding NRYR demonstrated a significant decrease in LDL-C levels with a net absolute/percent change of -7.95 mg/dL (95% CI: -13.79 to -2.11 mg/dL; P = 0.008)/-5.05% (95% CI: -8.87% to -1.24%; P = 0.009) at 1 month, but the effect was not significant at 3 months. Adverse event rates were similar across the 4 groups.

CONCLUSIONS

NRYR alone lowered LDL-C levels, and its combination with simvastatin was associated with numerically but not significantly lower LDL-C levels than using simvastatin alone. (ChiCTR2200064214, ChiCTR2200064215).

Для цитирования: Liu Fangchao, Chen Shufeng, Liang Fengchao, Li Jianxin, Huang Keyong, Sun Yingxian, Wang Qing, Wu Shouling, Ma Mingfeng, Yu Ling, Lin Jinchun, Lu Xiangfeng, Huang Jianfeng, Gu Dongfeng. Natto Red Yeast Rice Supplement Regulates Lipid Profiles: A Multicenter, Double-Placebo, Double-Blinded, Randomized Controlled Trial.. JACC. Asia. 2026. DOI: 10.1016/j.jacasi.2026.03.019.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.